MedPath
HSA Approval

DIAZEPAM LIPURO INJECTION 10 mg/2 ml

SIN08242P

DIAZEPAM LIPURO INJECTION 10 mg/2 ml

DIAZEPAM LIPURO INJECTION 10 mg/2 ml

July 4, 1995

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

N05BA01

diazepam

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MELSUNGEN AG

Active Ingredients

DIAZEPAM

10 mg/2 ml

Diazepam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIAZEPAM LIPURO INJECTION 10 mg/2 ml - HSA Approval | MedPath